1. Home
  2. BIVI vs KFFB Comparison

BIVI vs KFFB Comparison

Compare BIVI & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • KFFB
  • Stock Information
  • Founded
  • BIVI 2013
  • KFFB 2005
  • Country
  • BIVI United States
  • KFFB United States
  • Employees
  • BIVI N/A
  • KFFB N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • KFFB Savings Institutions
  • Sector
  • BIVI Health Care
  • KFFB Finance
  • Exchange
  • BIVI Nasdaq
  • KFFB Nasdaq
  • Market Cap
  • BIVI 18.6M
  • KFFB 21.0M
  • IPO Year
  • BIVI N/A
  • KFFB 2005
  • Fundamental
  • Price
  • BIVI $0.97
  • KFFB $2.91
  • Analyst Decision
  • BIVI
  • KFFB
  • Analyst Count
  • BIVI 0
  • KFFB 0
  • Target Price
  • BIVI N/A
  • KFFB N/A
  • AVG Volume (30 Days)
  • BIVI 210.2K
  • KFFB 6.0K
  • Earning Date
  • BIVI 05-12-2025
  • KFFB 05-12-2025
  • Dividend Yield
  • BIVI N/A
  • KFFB N/A
  • EPS Growth
  • BIVI N/A
  • KFFB N/A
  • EPS
  • BIVI N/A
  • KFFB N/A
  • Revenue
  • BIVI N/A
  • KFFB $8,308,000.00
  • Revenue This Year
  • BIVI N/A
  • KFFB N/A
  • Revenue Next Year
  • BIVI N/A
  • KFFB N/A
  • P/E Ratio
  • BIVI N/A
  • KFFB N/A
  • Revenue Growth
  • BIVI N/A
  • KFFB 13.79
  • 52 Week Low
  • BIVI $0.62
  • KFFB $1.96
  • 52 Week High
  • BIVI $7.50
  • KFFB $3.62
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 42.25
  • KFFB 65.27
  • Support Level
  • BIVI $0.88
  • KFFB $2.65
  • Resistance Level
  • BIVI $1.03
  • KFFB $3.00
  • Average True Range (ATR)
  • BIVI 0.07
  • KFFB 0.12
  • MACD
  • BIVI -0.02
  • KFFB 0.03
  • Stochastic Oscillator
  • BIVI 23.97
  • KFFB 71.93

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About KFFB Kentucky First Federal Bancorp

Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.

Share on Social Networks: